A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Insulin detemir
Esatenolol
The serum concentration of Esatenolol can be increased when it is combined with Levomilnacipran.
Insulin detemir
Bucindolol
The serum concentration of Bucindolol can be increased when it is combined with Levomilnacipran.
Insulin detemir
Anisodamine
The serum concentration of Anisodamine can be increased when it is combined with Levomilnacipran.
Insulin detemir
Talinolol
The serum concentration of Talinolol can be increased when it is combined with Levomilnacipran.
Insulin detemir
Levobetaxolol
The serum concentration of Levobetaxolol can be increased when it is combined with Levomilnacipran.
Insulin detemir
Arotinolol
The serum concentration of Arotinolol can be increased when it is combined with Levomilnacipran.
Insulin detemir
Indenolol
The serum concentration of Indenolol can be increased when it is combined with Levomilnacipran.
Insulin detemir
Bupranolol
The serum concentration of Bupranolol can be increased when it is combined with Levomilnacipran.
Insulin detemir
Bopindolol
The serum concentration of Bopindolol can be increased when it is combined with Levomilnacipran.
Insulin detemir
Bufuralol
The serum concentration of Bufuralol can be increased when it is combined with Levomilnacipran.
Insulin detemir
Nebivolol
The serum concentration of Nebivolol can be increased when it is combined with Levomilnacipran.
Insulin detemir
Celiprolol
The serum concentration of Celiprolol can be increased when it is combined with Levomilnacipran.
Insulin detemir
Dexpropranolol
The serum concentration of Dexpropranolol can be increased when it is combined with Levomilnacipran.
Insulin detemir
Remimazolam
The risk or severity of adverse effects can be increased when Remimazolam is combined with Levomilnacipran.
Insulin detemir
Lithium cation
The risk or severity of adverse effects can be increased when Lithium cation is combined with Levomilnacipran.
Insulin detemir
Lemborexant
The risk or severity of adverse effects can be increased when Lemborexant is combined with Levomilnacipran.
Insulin detemir
Hexobarbital
The risk or severity of adverse effects can be increased when Hexobarbital is combined with Levomilnacipran.
Insulin detemir
Aripiprazole lauroxil
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Aripiprazole lauroxil.
Insulin detemir
Nordazepam
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Nordazepam.
Insulin detemir
Clopenthixol
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Clopenthixol.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3